HGHRX Mutual Fund (The Hartford Healthcare Fund Cl R3) is managed by Hartford Funds with $16.4M in net assets. HGHRX expense ratio is 1.63%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-12-22.

HGHRX performance shows a YTD return of 4.88%. The 1-year return is 32.46% and the 5-year return is 5.10%. HGHRX dividend yield stands at 3.38%, paid annually.

HGHRX top holdings include Eli Lilly And Company (13.1%), Merck & Co. Inc. (5.7%), JOHNSON AND JOHNSON (5.1%), United Health Group (4.6%), Abbvie Inc Health Care (3.8%). View all HGHRX holdings, sector breakdown, or dividend history.

HGHRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHRX alternatives are available via the screener, along with tax-loss harvesting opportunities.